Immunogenicity and viability of alpha-class II immunotoxin-treated pig islet cells.
Mullen
Y
Y
Dental Research Institute, UCLA 90024.
Shiogama
T
T
Ozawa
A
A
Leonard
J E
JE
Papoian
T
T
Tsunoda
T
T
Terada
M
M
Motojima
K
K
Brown
J
J
D000818:Animals; D000911:Antibodies, Monoclonal; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004261:DNA Replication; D000949:Histocompatibility Antigens Class II / Q000032:analysis*; D000922:Immunotoxins / Q000494:pharmacology*; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000166:cytology / Q000276:immunology*; D016381:Islets of Langerhans Transplantation; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D008819:Mice, Nude; D012276:Ricin / Q000494:pharmacology*; D013552:Swine
D000911:Antibodies, Monoclonal; D000949:Histocompatibility Antigens Class II; D000922:Immunotoxins; D007328:Insulin; D012276:Ricin